Functional Effects of a Restrictive-Cardiomyopathy-Linked Cardiac Troponin I Mutation (R145W) in Transgenic Mice

Yuhui Wen, Yuanyuan Xu, Yingcai Wang, Jose Renato Pinto, James D. Potter, W. Glenn Kerrick

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The human cardiac troponin I (hcTnI) mutation R145W has been associated with restrictive cardiomyopathy. In this study, simultaneous measurements of ATPase activity and force in skinned papillary fibers from hcTnI R145W transgenic mice (Tg-R145W) were explored. Tg-R145W fibers showed an ∼ 13-16% increase in maximal Ca2+-activated force and ATPase activity compared to hcTnI wild-type transgenic mice. The force-generating cross-bridge turnover rate (g) and the energy cost (ATPase/force) were the same in all groups of fibers. Also, the Tg-R145W fibers showed a large increase in the Ca2+ sensitivity of both force development and ATPase. In intact fibers, the mutation caused prolonged force and intracellular [Ca2+] transients and increased time to peak force. Analysis of force and Ca2+ transients showed that there was a 40% increase in peak force in Tg-R145W muscles, which was likely due to the increased Ca2+ transient duration. The above cited results suggest that: (1) there would be an increase in resistance to ventricular filling during diastole resulting from the prolonged force and Ca2+ transients that would result in a decrease in ventricular filling (diastolic dysfunction); and (2) there would be a large (approximately 53%) increase in force during systole, which may help to partly compensate for diastolic dysfunction. These functional results help to explain the mechanisms by which these mutations give rise to a restrictive phenotype.

Original languageEnglish
Pages (from-to)1158-1167
Number of pages10
JournalJournal of Molecular Biology
Volume392
Issue number5
DOIs
StatePublished - Oct 9 2009

Fingerprint

Restrictive Cardiomyopathy
Troponin I
Transgenic Mice
Adenosine Triphosphatases
Mutation
Diastole
Systole
Phenotype
Costs and Cost Analysis
Muscles

Keywords

  • Ca force transients
  • cross-bridge
  • R145W
  • RCM
  • troponin

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Functional Effects of a Restrictive-Cardiomyopathy-Linked Cardiac Troponin I Mutation (R145W) in Transgenic Mice. / Wen, Yuhui; Xu, Yuanyuan; Wang, Yingcai; Pinto, Jose Renato; Potter, James D.; Kerrick, W. Glenn.

In: Journal of Molecular Biology, Vol. 392, No. 5, 09.10.2009, p. 1158-1167.

Research output: Contribution to journalArticle

@article{0be5450f99c541cbbd66da448de5e37f,
title = "Functional Effects of a Restrictive-Cardiomyopathy-Linked Cardiac Troponin I Mutation (R145W) in Transgenic Mice",
abstract = "The human cardiac troponin I (hcTnI) mutation R145W has been associated with restrictive cardiomyopathy. In this study, simultaneous measurements of ATPase activity and force in skinned papillary fibers from hcTnI R145W transgenic mice (Tg-R145W) were explored. Tg-R145W fibers showed an ∼ 13-16{\%} increase in maximal Ca2+-activated force and ATPase activity compared to hcTnI wild-type transgenic mice. The force-generating cross-bridge turnover rate (g) and the energy cost (ATPase/force) were the same in all groups of fibers. Also, the Tg-R145W fibers showed a large increase in the Ca2+ sensitivity of both force development and ATPase. In intact fibers, the mutation caused prolonged force and intracellular [Ca2+] transients and increased time to peak force. Analysis of force and Ca2+ transients showed that there was a 40{\%} increase in peak force in Tg-R145W muscles, which was likely due to the increased Ca2+ transient duration. The above cited results suggest that: (1) there would be an increase in resistance to ventricular filling during diastole resulting from the prolonged force and Ca2+ transients that would result in a decrease in ventricular filling (diastolic dysfunction); and (2) there would be a large (approximately 53{\%}) increase in force during systole, which may help to partly compensate for diastolic dysfunction. These functional results help to explain the mechanisms by which these mutations give rise to a restrictive phenotype.",
keywords = "Ca force transients, cross-bridge, R145W, RCM, troponin",
author = "Yuhui Wen and Yuanyuan Xu and Yingcai Wang and Pinto, {Jose Renato} and Potter, {James D.} and Kerrick, {W. Glenn}",
year = "2009",
month = "10",
day = "9",
doi = "10.1016/j.jmb.2009.07.080",
language = "English",
volume = "392",
pages = "1158--1167",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Functional Effects of a Restrictive-Cardiomyopathy-Linked Cardiac Troponin I Mutation (R145W) in Transgenic Mice

AU - Wen, Yuhui

AU - Xu, Yuanyuan

AU - Wang, Yingcai

AU - Pinto, Jose Renato

AU - Potter, James D.

AU - Kerrick, W. Glenn

PY - 2009/10/9

Y1 - 2009/10/9

N2 - The human cardiac troponin I (hcTnI) mutation R145W has been associated with restrictive cardiomyopathy. In this study, simultaneous measurements of ATPase activity and force in skinned papillary fibers from hcTnI R145W transgenic mice (Tg-R145W) were explored. Tg-R145W fibers showed an ∼ 13-16% increase in maximal Ca2+-activated force and ATPase activity compared to hcTnI wild-type transgenic mice. The force-generating cross-bridge turnover rate (g) and the energy cost (ATPase/force) were the same in all groups of fibers. Also, the Tg-R145W fibers showed a large increase in the Ca2+ sensitivity of both force development and ATPase. In intact fibers, the mutation caused prolonged force and intracellular [Ca2+] transients and increased time to peak force. Analysis of force and Ca2+ transients showed that there was a 40% increase in peak force in Tg-R145W muscles, which was likely due to the increased Ca2+ transient duration. The above cited results suggest that: (1) there would be an increase in resistance to ventricular filling during diastole resulting from the prolonged force and Ca2+ transients that would result in a decrease in ventricular filling (diastolic dysfunction); and (2) there would be a large (approximately 53%) increase in force during systole, which may help to partly compensate for diastolic dysfunction. These functional results help to explain the mechanisms by which these mutations give rise to a restrictive phenotype.

AB - The human cardiac troponin I (hcTnI) mutation R145W has been associated with restrictive cardiomyopathy. In this study, simultaneous measurements of ATPase activity and force in skinned papillary fibers from hcTnI R145W transgenic mice (Tg-R145W) were explored. Tg-R145W fibers showed an ∼ 13-16% increase in maximal Ca2+-activated force and ATPase activity compared to hcTnI wild-type transgenic mice. The force-generating cross-bridge turnover rate (g) and the energy cost (ATPase/force) were the same in all groups of fibers. Also, the Tg-R145W fibers showed a large increase in the Ca2+ sensitivity of both force development and ATPase. In intact fibers, the mutation caused prolonged force and intracellular [Ca2+] transients and increased time to peak force. Analysis of force and Ca2+ transients showed that there was a 40% increase in peak force in Tg-R145W muscles, which was likely due to the increased Ca2+ transient duration. The above cited results suggest that: (1) there would be an increase in resistance to ventricular filling during diastole resulting from the prolonged force and Ca2+ transients that would result in a decrease in ventricular filling (diastolic dysfunction); and (2) there would be a large (approximately 53%) increase in force during systole, which may help to partly compensate for diastolic dysfunction. These functional results help to explain the mechanisms by which these mutations give rise to a restrictive phenotype.

KW - Ca force transients

KW - cross-bridge

KW - R145W

KW - RCM

KW - troponin

UR - http://www.scopus.com/inward/record.url?scp=70149123629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70149123629&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2009.07.080

DO - 10.1016/j.jmb.2009.07.080

M3 - Article

C2 - 19651143

AN - SCOPUS:70149123629

VL - 392

SP - 1158

EP - 1167

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 5

ER -